EP Patent

EP0324597A2 — Fibrin selective two-chain plasminogen activator

Assigned to Oscient Pharmaceuticals Corp · Expires 1989-07-19 · 37y expired

What this patent protects

A fibrin specific two-chain plasminogen activator in a therapeutic dosage form. A method is also provided for dissolving clots in vivo by application to the body of a fibrin specific two-chain plasminogen activator in therapeutic dosage form.

USPTO Abstract

A fibrin specific two-chain plasminogen activator in a therapeutic dosage form. A method is also provided for dissolving clots in vivo by application to the body of a fibrin specific two-chain plasminogen activator in therapeutic dosage form.

Drugs covered by this patent

minocycline-hydrochloride (MINOCYCLINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP0324597A2
Jurisdiction: EP
Classification: —
Expires: 1989-07-19
Drug substance claim: No
Drug product claim: No
Assignee: Oscient Pharmaceuticals Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.